A review of the biochemistry, metabolism and clinical benefits of thiamin(e) and its derivatives

Evidence-based Complementary and Alternative Medicine

Volumn 3, Issue 1, 2006, Pages 49-59

  Lonsdale, Derrick ^a  

^a Preventive Medicine Group   (United States)

Author keywords

Disulfide; Oxidative stress; Thiamine deficiency

Indexed keywords

ALLITHIAMINE DERIVATIVE; BENFOTIAMINE; FURSULTIAMINE; PROSULTIAMINE; THIAMINE ALLYL DISULFIDE; THIAMINE DERIVATIVE; UNCLASSIFIED DRUG;

ALTERNATIVE MEDICINE; BERIBERI; CHEMICAL ANALYSIS; ENERGY METABOLISM; GLUCOSE METABOLISM; HUMAN; MALNUTRITION; NONHUMAN; NUTRITION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; THIAMINE DEFICIENCY; VITAMIN METABOLISM;

EID: 33745698824     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1093/ecam/nek009     Document Type: Review

References (123)

1. Lonsdale D, Shamberger RJ. Red cell transketolase as an indicator of nutritional deficiency. Am J Clin Nutr 1980;33:205-211.
2. Inouye K, Katsura E. Etiology and pathology of beriberi. In: Shimazono N, Katsura E, (eds). Beriberi and Thiamine. Tokyo: Igaku Shoin Ltd, 1965; 1-28.
3. Jansen BCT, Donath WF. On the isolation of the anti-beriberi vitamin. Proc K Acad Wet Amsterdam 1926;29:1390.
4. Williams RR. Chemistry of thiamine (vitamin B1). JAMA 1938;110:727-31.
5. Peters RA. The biochemical lesion in vitamin B1 deficiency. Lancet 1936;i:1162-5.
6. Flodin NW. Thiamine (vitamin B1). In: Alan R. (ed). Current Topics in Nutrition and Disease. New York: Liss, Inc., 1988; 103-16.
7. Brin M. Defects of pyruvate and pentose metabolism in relationship to transketolase activity in rats and man and to the startle response in thiamine-deficient rats. In: Wolstenholme GEW, O'Connor M, (eds). Thiamine Deficiency. Boston: Little, Brown and Company, 1967; 87-102.
8. Minz B. Sur la liberation de la vitamin par le tronc isole du nerf pneumogastrique soumis a la excitation electirique. C.R. Soc Biol (Paris) 1938;127:1251-3.
9. Cooper JR, Pincus JH. The role of thiamine in nervous tissue. Neurochem Res 1979;4:223-39.
10. Iwata H, Yabushita Y, Doi T, Matsuda T. Synthesis of thiamine triphosphate in rat brain in vivo. Neurochem Res 1985;10:779-87.
11. Bettendorff L, Michel-Cahay C, Grandfils C, DeRycker C, Schoffeniels E. Thiamine triphosphate and membrane-associated thiamine phosphatases in the electric organ of Electrophorus electricus. J Neurochem 1987;49:495-502.
12. Bettendorff L, Hennuy B, De Cherek A, Wins P. Chloride permeability of rat brain vesicles correlates with thiamine triphosphate content. Brain Res 1994;652:157-160.
13. Bettendorff L, Kolb HA, Schoffeniels E. Thiamine triphosphate activates anion channels of large unit conductance in neuroblastoma cells. J Membr Biol 1993;136:281-288.
14. Makarchikov AE, Lakaye B, Gulyai IE, Czerniecki J, Coumans B, Wins P, et al. Thiamine triphosphatase and thiamine triphosphatase activities: from bacteria to mammals. Cell Mol Life Sci 2003;60:1477-88.
15. Ganapathy V, Smith SB, Prasad PD. SLC19: the folate/thiamine transporter family. Pflugers Arch 2004;447:641-6.
16. Nabokina SM, Said HM. Characterization of the 5′-regulating region of the human thiamin transporter SLC19A3: in vitro and in vivo studies. Am J Physiol Gastrointest Liver Physiol 2004;287:G822-9.
17. World Health Organization. Thiamine deficiency and its prevention and control in major emergencies. Report no: WHO/NHD/99.13 Geneva: Department of Nutrition for Health and Development, WHO, 1999.
18. Fattal-Valegski A, Kesler A, Sela B, Nitzan-Kaluski D, Rotstein M, Mesterman R, et al. Outbreak of life threatening thiamine deficiency in infants in Israel caused by a defective soy based formula. Pediat 2005;115:es33-8.
19. Lonsdale D. Thiamine metabolism in disease. Crit Rev Lab Sci 1975; 5:289-313.
20. Platt BS. Thiamine deficiency in human beriberi and in Wernicke's encephalopathy. In: Wolstenholme GEW, O'Connor M, (eds). Thiamine Deficiency. Boston: Little, Brown and Company, 1967; 135-43.
21. Inouye K, Katsura E. Clinical signs and metabolism of beriberi patients. In: Shimazono N, Katsura E, (eds). Beriberi and Thiamine. Tokyo: Igaku Shoin Ltd, 1965; 29-63.
22. Lonsdale D. The syndrome of functional dysautonomia. Med Hypoth 1981;7:495-502.
23. Lonsdale D. Asymmetric functional dysautonomia. J Nutr Med 1990; 1:59-61.
24. Lonsdale D. Nutritional therapy in children with functional disorders of activity, behavior, attention and learning. Clin Pract Altern Med 2001;2:196-203.
25. Elmadfa I, Majchrzak D, Rust P, Genser D. The thiamine status of adult humans depends on carbohydrate intake. Int J Vitam Nutr Res 2001; 71:217-21.
26. Shangari N, Bruce WR, Poon R, O'Brien PJ. Toxicity of glyoxals-role of oxidative stress, metabolic detoxification and thiamine deficiency. Biochem Soc Trans 2003;31:1390-3.
27. Coghlan HC, Phares P, Cowley M, Copley D, James TN. Dysautonomia in mitral valve prolapse. Am J Med 1979;67:236-44.
28. Lonsdale D. Hypothesis and case reports: possible thiamin deficiency. J Am Coll Nutr 1990;9:13-17.
29. Lonsdale D. Wernicke's encephalopathy and hyperalimentation. JAMA 1978;239:1133.
30. Kril JJ. Neuropathology of thiamine deficiency disorders. Metab Brain Dis 1996;11(1):9-17.
31. Thauvin-Robinet C, Faivre L, Barbier ML, Chevret L, Bourgeois J, Netter JC, et al. Severe lactic acidosis and acute thiamin deficiency: a report of 11 neonates with unsupplemented total parenteral nutrition. J Inherit Metab Dis 2004;27:700-4.
32. O'Keefe ST, Tormey WP, Glasgow R, Lavan JN. Thiamine deficiency in hospitalized elderly patients. Gerontology 1994;40:18-24.
33. Williams RD, Mason HI, Power MH, et al. Induced thiamine (vitamin B1) deficiency in man; relation of depletion of thiamine to development of biochemical defect and of polyneuropathy. Arch Int Med 1943;71:38-53.
34. Onodera K, Tadano T, Sukai K, Kisara K, Ogura Y. Muricide induced by thiamine deficiency in rats. Folia Pharmacol (Japan) 1978; 74:641-8.
35. Onodera K, Kisura K. Persistent erection in thiamine deficient rats. Folia Pharmacol (Japan) 1978;74:649-52.
36. Mendoza CE, Rodriguez F, Rosenberg DG. Reversal of refractory congestive heart failure after thiamine supplementation: report of a case and review of literature. J Cardiovssc Pharmacol Ther 2003; 8: (4)313-6.
37. Roman GC. An epidemic in Cuba of optic neuropathy, sensorineural deafness, peripheral sensory neuropathy and dorsolateral myeloneuropathy. J Neurol Sci 1994;127:11-28.
38. Macias-Matos C, Rodriguez-Ojea A, Chi N, Jimenez S, Zulueta D. Biochemical evidence of thiamine depletion during the Cuban neuropathy epidemic, 1992-1993. Am J Clinc Nutr 1996;64:347-53.
39. Ogunlesi TA. Thiamine deficiency: a cause of childhood ataxia not to be ignored. Ann Trop Paediatr 2004;24:357-60.
40. Kaike H, Iiijima M, Mori K, Hattori N, Ito H, Hirayama M, et al. Postgastrectomy polyneuropathy with thiamine deficiency is identical to beriberi neuropathy. Nutrition 2004;20:961-6.
41. Mazevit D, Vassilev K, Perrigot M. Neuropthy with non-alcoholic thiamine deficiency: two cases of bladder disorders. Ann Readapt Med Phys 2005;48:43-7.
42. Sable HZ, Gubler CJ. (eds). Thiamin: twenty years of progress. Ann NY Acad Sci 1982;378:1-470.
43. McCandless DW. Energy metabolism in the lateral vestibular nucleus in pyrithiamin-induced thiamin deficiency. In: Sable HZ, Gubler CJ, (eds). Thiamin: Twenty Years of Progress. Ann NY Acad Sci 1982;378:355-64.
44. Plaitakis A, Hwang EC, Van Woert MH, Szilagyi PIA, Beri S. Effect of thiamin deficiency on brain neurotransmitter systems. In: Sable HZ, Gubler CJ, (eds). Thiamin: Twenty Years of Progress. Ann NY Acad Sci 1982;378:367-81.
45. Gibson G, Barclay L, Blass J. The role of the cholinergic system in thiamin deficiency. In: Sable HZ, Gubler CJ, (eds). Thiamin: Twenty Years of Progress. Ann NY Acad Sci 1982;378:382-403.
46. Lonsdale D. Effect of thiamine tetrahydrofurfuryl disulfide on audiogenic seizures in DBA/J2 mice. Dev Pharmacol Ther 1982;4:28-36.
47. Meador KJ, Nichols ME, Franke P, Durkin MW, Oberzan RL, Moore EE, et al. Evidence for a central cholinergic effect of high-dose thiamine. Ann Neurol 1993;34:724-6.
48. Blass JP, Gleason P, Brush D, DiPonte P, Thaler H. Thiamine and Alzheimer's disease. Arch Neurol 1988;45:833-5.
49. Meador K, Loring D, Nichols M, Zamrini E, Rivner M, Posas H, et al. Preliminary findings of high dose thiamine in dementia of Alzheimer's type. J Geriatr Psychiatry Neurol 1993;6:222-9.
50. Mastrogiacoma F, Bettendorff L, Grisar T, Kish SJ. Brain thiamine, its phosphate esters, and its metabolizing enzymes in Alzheimer's disease. Ann Neurol 1996;39:585-91.
51. Adickes ED, Buehler BA, Sanger WG. Familial lethal sleep apnea. Hum Genet 1986;73:39-43.
52. Cooper JR, Pincus JH, Itokawa Y, Piros K. Experience with phosphoryl transferase inhibition in subacute necrotizing encephalomyelopathy. N Engl J Med 1970;283:793-5.
53. Cooper JR, Itokawa Y, Pincus JH. Thiamine triphosphate deficiency in subacute necrotizing encephalomyelopathy. Science 1969;164:72-3.
54. Lonsdale D. Sudden infant death syndrome requires genetic predisposition, some form of stress and marginal malnutrition. Med Hypoth 2001;57:382-6.
55. Fehily L. Human milk intoxication due to B1 avitaminosis. Brit Med J 1944;2:590-2.
56. Jeffrey HE, McCleary BV, Hensley WJ, Read DJC. Thiamine deficiency - a neglected problem of infants and mothers-possible relationship to sudden infant death syndrome. Aust NZ H Obst Gynaecol 1985;25:198-202.
57. Lonsdale D, Mercer RD. Primary hypoventilation syndrome. Lancet 1972;ii:487 (Letter).
58. Lonsdale D. Treatment of threatened SIDS with megadose thiamine hydrochloride. Pediat Res 1977;11:379 (Abstr).
59. Lonsdale D. Thiamine deficiency and sudden deaths. Lancet 1990; ii:376.
60. Lonsdale D, Nodar RH, Orlowski JP. The effects of thiamine on abnormal brainstem auditory evoked potentials. Cleve Clin Quart 1979; 46:83-8.
61. Lonsdale D, Nodar RH, Orlowski JP. Brainstem dysfunction in infants responsive to thiamine disulfide; preliminary studies in four patients. Clin EEG 1982;13:82-8.
62. Barker JN, Jordan F. Phrenic thiamin and neuropathy in sudden infant deaths. In: Sable HZ, Gubler CJ, (eds). Thiamin: Twenty Years of Progress. Ann NY Acad Sci 1982;378:449-52.
63. van de Borne P. New evidence of baroreflex dysfunction in congenital central hypoventilation syndrome. Clin Sci (Lond) 2005;108:215-6.
64. Macey PM, Woo MA, Macey KE, Keens TG, Saeed MM, Alger JR, et al. Hypoxia reveals posterior thalamic, cerebellar, midbrain and limbic deficits in congenital central hypoventilation syndrome. J Appl Physiol 2005;98:958-69.
65. Kimura M, Itokawa Y. Effects of calcium and magnesium deficiency on thiamine distribution in rat brain and liver. J Neurochem 1977;28:389-93.
66. Dyckner T, Elk B, Nyhlin H, Wester PO. Aggravation of thiamine deficiency by magnesium depletion. A case report. Acta Scand 1985; 218:129-31.
67. Eisinger J, Bagneres D, Arroyo P, Plantamura A, Ayavou T. Effect of magnesium, high energy phosphates, piracetam and thiamin on erythrocyte transketolase. Magnes Res 1994;7:59-61.
68. 2+ in TPP-dependent riboswitch. FEBS Lett 2005;579:2583-8.
69. Lonsdale D, Faulkner WR, Price JW, Smeby RR. Intermittent cerebellar ataxia associated with hyperpyruvic acidemia, hyperalaninemia, and hyperalaninuria. Pediatrics 1969;43:1025-34.
70. Blass J. Abnormalities in pyruvate dehydrogenase and neurologic function. Intern J Neurosci 1972;4:65-9.
71. Narisawa K, Endo H, Miyabayashi S, Tada K. Thiamine responsive pyruvate dehydrogenase deficiency. J Nutr Sci Vitaminol (Tokyo) 1992;Spec No:585-8.
72. Dancis J, Hutzler J, Rokkones T. Intermittent branched-chain ketonuria: variant of maple-syrup-urine disease. N Engl J Med 1967;276:84-9.
73. Elsas LJ, Danner DJ. The role of thiamin in maple syrup urine disease. In: Sable HZ, Gubler CJ, (eds). Thiamin: Twenty Years of Progress. Ann NY Acad Sci 1982;378:404-20.
74. Lonsdale D. Recurrent febrile lymphadenopathy treated with large doses of vitamin B1: report of two cases. Dev Pharmacol Ther 1980;1:254-64.
75. Lockman PR, McAfee JH, Geldenhuys WJ, Allen DD. Cation transport specificity at the blood-brain barrier. Neurochem Res 2004;29:2245-50.
76. Ozdemir MA, Alcakus M, Kuroglu, Gunes T, Torun YA. TRMA syndrome (thiamine-responsive megaloblastic anemia): a case report and review of the literature. Pediatr Diabetes 2002;3:205-9.
77. Lagarde WH, Underwood LE, Moats-Staats BM, Calikoglu AS. Novel mutation in the SLC19A2 gene in an African-American female with thiamine-responsive megaloblastic anemia syndrome. Am J Med Genet A 2004;125:299-305.
78. Oishi K, Barchi M, Au AC, Gelb BD, Diaz GA. Male infertility due to germ cell apoptosis in mice lacking the thiamin carrier, Tht1. A new insight into the critical role of thiamin in spermatogenesis. Dev Biol 2004;266:299-309.
79. Lorber A, Gazit AZ, Khoury A, Schwartz Y, Mandel H. Cardiac manifestations in thiamine-responsive megaloblastic anemia syndrome. Peiatr Cardiol 2003;24:476-81.
80. Rindi G, Laforenza U. Thiamine intestinal transport and related issues: recent aspects. Proc Soc Exp Biol Med 2000;224:246-55.
81. Lonsdale D. Biochemical studies in functional dysautonomia. In: Lonsdale D. (ed). A Nutritionist's Guide to the Clinical Use of Vitamin B1.. Tacoma WA: Life Sciences Press, 1987; 78-115.
82. Boni L, Kieckens L, Hendricx A. An evaluation of a modified erythtocyte transketolase assay for assessing thiamine nutritional adequacy. J Nutr Sci Viatminol 1980;26:507-14.
83. Jeyasingham MD, Pratt O, Burns A, Shaw GK, Thomson AD, Marsh A. The activation of red blood cell transketolase in groups of patients especially at risk from thiamin deficiency. Psych Med 1987;117:311-8.
84. Lonsdale D. Red cell transketolase studies in a private practice specializing in nutritional correction. J Am Coll Nutr 1988;7:61-7.
85. Blass JP, Gibson GE. Abnormality of a thiamine-requiring enzyme in patients with Wernicke-Korsakoff syndrome. N Engl J Med 1977;297:1367-70.
86. Gibson GE, Zhang H. Interactions of oxidative stress with thiamine homeostasis promote neurodegeneration. Neurochem International 2002;40:493-504.
87. Lonsdale D, Shamberger RJ, Audhya T. Treatment of autistic spectrum children with thiamine tetrahydrofurfuryl disulfide: a pilot study. Neuroendocrinol Lett 2002;23:303-8.
88. Schenk G, Duggleby RG, Nixon FF. Properties and functions of the thiamin diphosphate dependent enzyme transketolase. Int J Biochem Cell Biol 1998;30:1297-1318.
89. Muri RM, Von Overbeck J, Furrer J, Ballmer PE. Thiamin deficiency in HIV-positive patients: evaluation by erythrocyte transketolase activity and thiamin pyrophosphate effect. Clin Nutr 1999;18:375-78.
90. Cheong JH, Seo DO, Ryu JR, Shin CY, Kim YT, Kim HC, et al. Lead induced thiamine deficiency in the brain decreased the threshold of electroshock seizure in rat. Toxicology 1999;133:105-13.
91. Olkowski AA, Gooneratne SR, Christensen DA. The effects of thiamine and EDTA on biliary and urinary lead excretion in sheep. Toxicol Lett 1991;59:153-9.
92. Kim JS, Hamilton DL, Blakley BR, Rousseaux CG. The effects of thiamin on lead metabolism: whole body retention of lead-203. Toxicol Lett 1991;56:43-52.
93. Fujita A. Thiaminase. In: Nord FF. (ed.). Adv Enzymol. Interscience Publishers 1954;15:389-421.
94. Edwin EE, Gwyneth L. The implication of ruminal thiaminase in cerbrocortical necrosis. Proc Nutr Sci 1971;330:7A.
95. Murata K. Thiaminase. In: Shimazono N, Katsura E, (eds). Beriberi and Thiamine. Tokyo: Igaku Shoin Ltd, 1965; 220-54.
96. Nishimune T, Watanable Y, Okazaki H, Akai H. Thiamin is decomposed due to Anaphe spp. Entomophagy in seasonal ataxia patients in Nigeria. J Nutr 2000;130:1625-8.
97. Fujiwara M, Watanabe H, Katsui K. Allithiamine, a newly found derivative of vitamin B1. J Biochem 1954;41:29-39.
98. Shimazono N, Katsura E. (eds). Beriberi and Thiamine. Tokyo: Igaku Shoin Ltd., 1965; 1-295.
99. Fujiwara M. Absorption, excretion and fate of thiamine and its derivatives in [the] human body. In: Shimazono N, Katsura E, (eds). Thiamine and Beriberi. Tokyo: Igaku Shoin Ltd., 1965; 179-213.
100. Bitsch R, Wolf M, Moller J, Heuzeroth L, Graneklee D. Bioavailability assessment of the lipophilic benfotiamine as compared to a water-soluble thiamine derivative. Ann Nutr Metab. 1991;35:292-6.
101. Thornalley PJ. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. Diabetes 2003;57:2110-20.
102. Beltramo E, Berrone E, Buttiglieri S, Porta M. Thiamine and benfotiamine prevent increased apaptosis in endothelial cells and pericytes cultured in high glucose. Diabetes Metab Res Rev 2004;20: (4)330-6.
103. Haupt E, Ledermann H, Kopcke W. Benfotiamine in the treatment of diabetic polyneuropathy - a three-week randomized, controlled pilot study (BEDIP study). Int J Clin Pharmacol Ther 2005;43:71-77, Erratum in: Int J Clin Pharmacol Ther 2005;43:304.
104. Lonsdale D. Thiamine metabolism in disease. Crit Rev Lab Sci 1975; 5:289-313.
105. Lonsdale D, Kissling CD. Clinical trials with thiamine tetrahydrofurfuryl disulfide (TTFD) in Down's syndrome. J Orthomol Med 1987; 1:169-75.
106. Lonsdale D. Thiamine and its fat soluble derivatives as therapeutic agents. Int Clin Rev 1987;7:114-25.
107. Lonsdale D. Thiamine tetrahydrofurfuryl disulfide: a little known therapeutic agent. Med Sci Monit 2004;10:RA199-203.
108. Kikuchi S, Nishikawa K, Suzuoki Z. The metabolism of thiamine tetrahydrofurfuryl disulfide in the rat, rabbit and man. Eur J Pharmacol 1970;9:367-73.
109. Fujita T, Suzuoki Z. Enzymatic studies on the metabolism of the tetrahydrofurfuryl mercaptan moiety of thiamine tetrahydrofurfuryl disulfide. I Microsomal S-transmethylase. J Biochem 1973;74:717-22.
110. Fujita T, Suzuoki Z, Kozuka S. Enzymatic studies on the metabolism of the tetrahydrofurfuryl mercaptan moiety of thiamine tetrahydrofurfuryl disulfide, II Sulfide and sulfoxide oxygenbases in microsomes. J Biochem 1973;74:723-32.
111. Fujita T, Suzuoki Z. Enzymatic studies on the metabolism of the tetrahydrofurfuryl mercaptan moiety of thiamine tetrahydrofurfuryl disulfide. III. Oxidative cleavage of the tetrahydrofuran moiety. J Biochem 1973;74:733-8.
112. Fujita T, Teraoka A, Suzuoki Z. Enzymatic studies on the metabolism of the tetrahydrofurfuryl mercaptan moiety of thiamine tetrahydrofurfuryl disulfide. IV. Induction of microsomal S-transmethylase, and sulfide and sulfoxide oxygenases in the drug-treated rat. J Biochem 1973;74:739-45.
113. Kitzushima Y. Anti-inflammatory effect of thiamine derivatives. Vitamins (Japan) 1967;36:305-10.
114. Matsui K, Nakahara H, Watanabe J, Tamatsu H, Nakayawa M, Nakayawa Y, et al. Inhibition by thiamine tetrahydrofurfuryl disulfide (TTFD) of the arachidonic acid cascade-line activation as evidenced in the heart-lung preparation of the dog. Jpn J Pharmacol 1985;39:375-79.
115. Djoenaidi W, Notermans SL. Thiamine tetrahdydrofurfuryl disulfide in nutritional polyneuropathy. Eur Arch Psychiatry Neurol Sci 1990;239:218-20.
116. Djoenaidi W, Notermans SL, Dunda G. Beriberi cardiomyopathy. Eur J Clin Nutr 1992;46:227-34.
117. Mimori Y, Katsuoka H, Nakamura S. Thiamine therapy in Alzheimer's disease. 1996;11:89-94.
118. Harada H, Rikimara F, Mori T, Tanaka M, Shiraishi K, Kato T. Electroencephalographic changes during intravenous olfactory stimulation in humans. Clin Electroencephalogr 2002;33:189-92.
119. Stepuro AL, Piletskaya TP, Stepuro U. Role of thiamine thiol forms in nitric oxide metabolism. Biochemistry (Mosc) 2005;70:339-49.
120. Schauss A. Diet, Crime and Delinquency. Berkeley, CA 94704: Parker House, 1981; 1-108.
121. Gray GE. Crime and diet: is there a relationship? Wld Rev Nutr Diet 1987;49:66-86.
122. Lonsdale D. Criminal behavior and nutrition. J Adv Med 1992; 5:115-23.
123. Lonsdale D. Crime and violence: a hypothetical explanation of its relationship with high calorie malnutrition. J Adv Med 1994;7:171-80.